Chicago, IL, United States of America

Louis Paul Deiss

This inventor holds 1 USPTO granted patent. Top assignee: Quark Biotech, Inc.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis Paul Deiss. Retrieved from https://idiyas.com/inventor/louis-paul-deiss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Louis Paul Deiss: Innovating Gene Identification in Biotechnology

Introduction

Louis Paul Deiss, a prominent inventor based in Chicago, IL, has made significant strides in the field of biotechnology. With his innovative approach, he has developed a unique method for gene identification, contributing to advancements in research and medical applications.

Latest Patents

Louis Paul Deiss holds one patent, which focuses on a gene identification method. This innovation emphasizes the importance of identifying specific genes, which can have substantial implications in genetic research, diagnostics, and therapeutic interventions.

Career Highlights

Deiss is affiliated with Quark Biotech, Inc., a company that is at the forefront of biotechnological innovations. His work there highlights his commitment to pushing the boundaries of genetic research and its applications in various medical fields.

Collaborations

Throughout his career, Louis Paul Deiss has collaborated with talented individuals such as Fruma Yehiely and Elena Efimova. These collaborations have fostered a dynamic environment for innovation and have facilitated the sharing of diverse expertise in the field.

Conclusion

Louis Paul Deiss exemplifies the spirit of innovation in biotechnology. His contributions, particularly in gene identification, underscore the vital role inventors play in advancing scientific understanding and improving health outcomes. As he continues his work at Quark Biotech, the future looks promising for groundbreaking discoveries that could change the landscape of genetic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…